Jan Smogorzewski to Off-Label Use
This is a "connection" page, showing publications Jan Smogorzewski has written about Off-Label Use.
Connection Strength
0.163
-
Off-label studies on ruxolitinib in dermatology: a review. J Dermatolog Treat. 2022 Mar; 33(2):606-612.
Score: 0.163
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.